Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Synthetic metagenome

ABSTRACT: Raw sequence reads of SARS-CoV-2/Escherichia coli/Human adenovirus 55/Saccharomyces cerevisiae synthetic controls

PROVIDER: PRJNA1028169 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26400200_1.fastq.gz	Fastqsanger.gz
	SRR26400201_1.fastq.gz	Fastqsanger.gz
	SRR26400202_1.fastq.gz	Fastqsanger.gz
	SRR26400203_1.fastq.gz	Fastqsanger.gz
	SRR26400204_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Saccharomyces cerevisiae synthetic construct strain:yWZ703

Project description:Saccharomyces cerevisiae synthetic chromosome IV

| PRJNA851090 | ENA

Saccharomyces cerevisiae synthetic construct strain:YCy2508

Project description:Saccharomyces cerevisiae synthetic tRNA neochromosome

| PRJNA868738 | ENA

Synthetic Lethality (SLAM) Project Data

Project description:Synthetic lethality is a type of genetic interaction in which two non-lethal mutations acting together result in a loss of viability. Such interactions are important for the insights they may offer into how gene functions are organized into distinct cellular processes. The datasets in this Series represent an effort to identify synthetic lethal genetic interactions in the yeast Saccharomyces cerevisiae on a genome-wide scale.

2013-02-28 | GSE14217 | GEO

Saccharomyces cerevisiae synthetic construct strain:yJL690 | isolate:BY4741

Project description:Saccharomyces cerevisiae synthetic chromosome I

| PRJNA899531 | ENA

Saccharomyces cerevisiae synthetic construct strain:yLHM1601 | isolate:BY4741

Project description:Saccharomyces cerevisiae synthetic chromosome IX

| PRJNA900304 | ENA

Expression data from the partially synthetic yeasts SynIXR-1D, -6B, -22D, and controls.

Project description:We have replaced the right arm of chromosome IX in Saccharomyces cerevisiae with a synthetic version to generate synIXR haploids. The synthetic chromosome features multiple sequeunce modifications. We analyzed gene expression by microarray analysis in three synIXR haploids (1D, 6B, and 22D) to detect any changes in synIXR transcripts or global compensatory changes. Biological triplicates of three synIXR haploids (1D, 6B, and 22D) and corresponding controls (either BY4741 or BY4742) were grown to mid-log phase and collected for mRNA isolation.

2011-09-13 | E-GEOD-31326 | biostudies-arrayexpress

Synthetic Lethality (SLAM) Project Data

2013-02-28 | E-GEOD-14217 | biostudies-arrayexpress

Expression data from the partially synthetic yeasts SynIXR-1D, -6B, -22D, and controls.

2011-09-14 | GSE31326 | GEO

Blood RNA-seq data from individuals during the UK Covid-19 lockdown, spanning sequential weeks from first PCR-confirmed SARS-CoV-2 infection, used to evaluate blood transcriptomic signatures of viral infection and identify host-response biomarkers of early SARS-CoV-2 infection

Project description:Healthcare workers were recruited at St Bartholomew’s Hospital, London, UK in the week of lockdown in the United Kingdom (between 23rd and 31st March 2020). Participants underwent weekly evaluation using a questionnaire and biological sample collection (including serological assays) for up to 16 weeks when attending for work and self-declared as fit to attend work at each visit, with further follow up samples collected at 24 weeks. Blood RNA sequencing data was to be used to identify host-response biomarkers of early SARS-CoV-2 infection, to evaluate existing blood transcriptomic signatures of viral infection, and to describe the underlying biology during SARS-CoV-2 infection. This submission includes a total of 172 blood RNA samples from 99 participants. Of these, 114 samples (including 16 convalescent samples collected 6 months after infection) were obtained from 41 SARS-CoV-2 cases, with the remaining 58 from uninfected controls. Participants with available blood RNA samples who had PCR-confirmed SARS-CoV-2 infection during follow-up were included as ‘cases’. Those without evidence of SARS-CoV-2 infection on nasopharyngeal swabs and who remained seronegative by both Euroimmun anti S1 spike protein and Roche anti nucleocapsid protein throughout follow-up were included as uninfected controls. ‘Cases’ include all available RNA samples, including convalescent samples at week 24 of follow-up for a subset of participants. For uninfected controls, we included baseline samples only. Sample class denotes weekly interval to positive SARS-CoV-2 PCR; non-infected controls (NIC); convalescent samples (Conv)_.

2021-07-07 | E-MTAB-10022 | biostudies-arrayexpress

Saccharomyces cerevisiae synthetic construct strain:YZY1178 | isolate:BY4741

Project description:Saccharomyces cerevisiae multiple synthetic chromosome consolidation - Syn6.5

| PRJNA914659 | ENA